Hereby we would like to inform you about the change in evaluation fees for Research Ethics Committee of the National Institute for Health Development.
Starting from the September 1, 2019, the following fees apply for the evaluation of the clinical trials and their amendments (according to the Medicinal Products Act):
- 383 euros for the initial evaluation of the clinical trial
- 200 euros for the evaluation of a substantial amendment.
Please see the Communication from the European Commission 2010/C 82/01 for the examples of substantial amendments.
The invoices issued in the first half of September will not be changed.
According to the directive of the director of National Institute for Health Development (number 1-1/24) Research Ethics Committee of the National Institute for Health Development (NIHD REC) will start operating from August 1, 2019.
NIHD REC carries out ethical scientific evaluation of biomedical, behavioural and social science research projects performed on humans.
Meetings of NIHD REC in 2020:
|Deadline for the submission of the documents||Date of the meeting|
|January 2||January 16|
|January 29||February 13|
|March 4||March 19|
|April 1||April 16|
|April 29||May 14|
|June 3||June 18|
|August 12||August 27|
|September 2||September 17|
|September 30||October 15|
|November 4||November 19|
|December 2||December 17|
Research Ethics Committee of the National Institute for Health Development
Tallinn 11619, Estonia
Tel: +372 659 3924
Fax: +372 659 3901